Advertisement

Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology

  • Katia Pauwels
  • Ruth Mampuys
  • Catherine Golstein
  • Didier Breyer
  • Philippe Herman
  • Marion Kaspari
  • Jean-Christophe Pagès
  • Herbert Pfister
  • Frank van der Wilk
  • Birgit Schönig
Announcements and Reports

Abstract

In Europe and beyond, several advisory bodies have been monitoring the developments in the field of Synthetic Biology. Reports have been sent to national governments for information on the developments and possible regulatory and risk assessment questions raised by this field. To put the issues in a broader perspective, four national biosafety advisory bodies (the French High Council for Biotechnology, the German Central Committee on Biological Safety, the Netherlands Commission on Genetic Modification and the Belgian Scientific Institute of Public Health (Biosafety and Biotechnology Unit)) decided to join forces and organize an international scientific workshop to review some of the latest scientific insights and look into possible challenges in the risk assessment of Synthetic Biology. The SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology took place on the 12th of December 2012 and gathered scientists from biosafety advisory bodies from fifteen European countries, from the European Food Safety Authority as well as representatives of the European Commission, together with research scientists selected for their excellence in the field. The workshop was divided into two sessions: the first session gave an overview of four major fields in Synthetic Biology. The second session was set up for discussion with a scientific panel and the audience to identify and address relevant questions for risk assessment raised by recent and future developments of Synthetic Biology. An overview of the workshop and the discussion points put forward during the day are discussed in this document.

Keywords

Synthetic Biology Risk assessment Biosafety GMOs New techniques Emerging risks 

References

  1. Acevedo-Rocha CG, Budisa N (2011) On the road towards chemically modified organisms endowed with a genetic firewall. Angew Chem Int Ed Engl 50:6960–6962CrossRefPubMedGoogle Scholar
  2. Carbonell P, Planson AG, Fichera D, Faulon JL (2011) A retrosynthetic biology approach to metabolic pathway design for therapeutic production. BMC Sys Biol 5:122CrossRefGoogle Scholar
  3. Carlson R (2003) The pace and proliferation of biological techniques. Biosecur Bioterror 1(3):1–12CrossRefGoogle Scholar
  4. Carr PA, Park JS, Lee YJ, Yu T, Zhang S, Jacobson JM (2004) Protein-mediated error correction for de novo DNA synthesis. Nucleic Acids Res 32(20):e162CrossRefPubMedGoogle Scholar
  5. Cello J, Paul AV, Wimmer E (2002) Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297(5583):1016–1018CrossRefPubMedGoogle Scholar
  6. COGEM (2013) Synthetic Biology: Update 2013. COGEM topic report CGM/20130117-01. http://www.cogem.net/index.cfm/en/publications/publicatie/synthetic-biology-update-2013. Accessed 15 Apr 2013
  7. Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S (2008) Virus attenuation by genome-scale changes in codon pair bias. Science 320(5884):1784–1787CrossRefPubMedGoogle Scholar
  8. Curran KA, Alper HS (2012) Expanding the chemical palate of cells by combining systems biology and metabolic engineering. Metab Eng 14(4):289–297CrossRefPubMedGoogle Scholar
  9. DFG, acatech, Leopoldina (2009) Synthetische Biologie —Standpunkte. Weinheim, Wiley VCHGoogle Scholar
  10. Dzieciol J, Mann S (2012) Designs for life: protocell models in the laboratory. Chem Soc 41:79–85Google Scholar
  11. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S, Krishnakumar R, Assad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Qi ZQ, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison CA 3rd, Smith HO, Venter JC (2010) Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329(5987):52–56CrossRefPubMedGoogle Scholar
  12. Mann S (2012) Systems of Creation: the emergence of life from non-living matter. Acc Chem Res 45(12):2131–2141CrossRefPubMedGoogle Scholar
  13. Marlière P (2009) The farther, the safer: a manifesto for securely navigating synthetic species away from the old living world. Syst Synth Biol 3:77–84CrossRefPubMedGoogle Scholar
  14. Marlière P, Patrouix J, Döring V, Herdewijn P, Tricot S, Cruveiller S, Bouzon M, Mutzel R (2011) Chemical Evolution of a Bacterial Genome. Angew Chem 123:7247–7252CrossRefGoogle Scholar
  15. Mueller S, Coleman JR, Papamichail D, Ward CB, Nimnual A, Futcher B, Skiena S, Wimmer E (2010) Live attenuated influenza virus vaccines by computer-aided rational design. Nature Biotechnol 28(7):732–736CrossRefGoogle Scholar
  16. Noireaux V, Maeda YT, Libchaber A (2011) Development of an artificial cell, from self-organization to computation and self-reproduction. Proc Natl Acad Sci USA 108:3473–3480CrossRefPubMedGoogle Scholar
  17. Pauwels K, Willemarck N, Breyer P, Herman D (2012) Synthetic Biology, latest developments, biosafety considerations and regulatory challenges. Scientific report from the Biosafety and Biotechnology Unit, Scientific Institute of Public Health, Belgium. http://www.biosafety.be/PDF/120911_Doc_Synbio_SBB_FINAL.pdf. Accessed 19 Apr 2013
  18. Planson AG, Carbonell P, Grigoras I, Faulon JL (2012) A retrosynthetic biology approach to therapeutics: from conception to delivery. Curr Opin Biotechnol 23:948–956CrossRefPubMedGoogle Scholar
  19. Schmidt M (2010) Xenobiology: A new form of life as the ultimate biosafety tool. Bio Essays 32:322–331Google Scholar
  20. Stano P, Luisi PL (2010) Achievements and open questions in the self-reproduction of vesicles and synthetic minimal cells. Chem Comm 46:3639–3653CrossRefPubMedGoogle Scholar
  21. Stano P, Carrara P, Kuruma Y, Souza T, Luisi PL (2011) Compartmentalized reactions as a case of soft-matter biotechnology: Synthesis of proteins and nucleic acids inside lipid vesicles. J Mater Chem 21:18887–18902CrossRefGoogle Scholar
  22. Stephanopoulos G (2012) Synthetic biology and metabolic engineering. ACS Synth Biol 1(11):514–525CrossRefPubMedGoogle Scholar
  23. Zentrale Kommission für die Biologische Sicherheit (2012) Monitoring der Synthetischen Biologie in Deutschland. http://www.bvl.bund.de/SharedDocs/Downloads/06_Gentechnik/ZKBS/01_Allgemeine_Stellungnahmen_deutsch/01_allgemeine_Themen/Synthetische_Biologie.pdf?__blob=publicationFile&v=3 Accessed 15 Apr 2013
  24. Zhang F, Carothers JM, Keasling J (2012) Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids. Nature Biotechnol 30:354–359CrossRefGoogle Scholar

Copyright information

© Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) 2013

Authors and Affiliations

  • Katia Pauwels
    • 1
  • Ruth Mampuys
    • 2
  • Catherine Golstein
    • 3
  • Didier Breyer
    • 1
  • Philippe Herman
    • 1
  • Marion Kaspari
    • 4
  • Jean-Christophe Pagès
    • 5
    • 3
  • Herbert Pfister
    • 6
    • 4
  • Frank van der Wilk
    • 2
  • Birgit Schönig
    • 4
  1. 1.Biosafety and Biotechnology Unit (SBB)Scientific Institute of Public HealthBrusselsBelgium
  2. 2.Netherlands Commission on Genetic Modification (COGEM)BilthovenThe Netherlands
  3. 3.High Council for Biotechnology (HCB)ParisFrance
  4. 4.Office of the Central Committee on Biological Safety (ZKBS)Federal Office of Consumer Protection and Food SafetyBerlinGermany
  5. 5.INSERM U966ToursFrance
  6. 6.Klinikum der Universität zu Köln, Institut für VirologieCologneGermany

Personalised recommendations